1. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs;Hex;Diabet Med,2012
2. The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010–2030;Holman;Diabet Med,2011
3. IMS Knowledge Link version 5. Drugs used in diabetes currently in phase III or in pre-registration. IMS Health, Lifecycle R&D Focus Source. Available from: http://knowledgelink.imshealth.com/. [Accessed March 13, 2013].
4. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. 2008. Available from: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf. [Accessed March 13, 2013].
5. TSD 9 The Identification, Review and Synthesis of Health State Utility Values from the Literature;Papaioannou,2010